Encompass Health Net Worth
Encompass Health Net Worth Breakdown | EHC |
Encompass Health Net Worth Analysis
Encompass Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Encompass Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Encompass Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Encompass Health's net worth analysis. One common approach is to calculate Encompass Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Encompass Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Encompass Health's net worth. This approach calculates the present value of Encompass Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Encompass Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Encompass Health's net worth. This involves comparing Encompass Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Encompass Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Encompass Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Encompass Health's net worth research are outlined below:
| Over 98.0% of the company shares are held by institutions such as insurance companies | |
| On 15th of October 2024 Encompass Health paid $ 0.17 per share dividend to its current shareholders | |
| Latest headline from zacks.com: Why Is Encompass Health Up 3.8 percent Since Last Earnings Report |
Encompass Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Encompass Health Corp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Encompass Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 7th of February 2024 Upcoming Quarterly Report | View | |
| 25th of April 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Encompass Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Encompass Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Encompass Health Corp backward and forwards among themselves. Encompass Health's institutional investor refers to the entity that pools money to purchase Encompass Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Td Global Investment Solutions – Td Epoch | 2024-09-30 | 1.7 M | Hhg Plc | 2024-06-30 | 1.6 M | Bank Of New York Mellon Corp | 2024-06-30 | 1.5 M | Brown Advisory Holdings Inc | 2024-09-30 | 1.5 M | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 1.4 M | Copeland Capital Management, Llc | 2024-09-30 | 1.3 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 1.1 M | Norges Bank | 2024-06-30 | 1.1 M | Massachusetts Financial Services Company | 2024-09-30 | 1.1 M | Vanguard Group Inc | 2024-09-30 | 10.3 M | Blackrock Inc | 2024-06-30 | 9 M |
Follow Encompass Health's market capitalization trends
The company currently falls under 'Large-Cap' category with a total capitalization of 10.36 B.Market Cap |
|
Project Encompass Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.08 | 0.05 | |
| Return On Capital Employed | 0.13 | 0.11 | |
| Return On Assets | 0.06 | 0.03 | |
| Return On Equity | 0.21 | 0.22 |
When accessing Encompass Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Encompass Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Encompass Health's profitability and make more informed investment decisions.
Please note, the presentation of Encompass Health's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Encompass Health's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Encompass Health's management manipulating its earnings.
Evaluate Encompass Health's management efficiency
Encompass Health Corp has Return on Asset of 0.0838 % which means that on every $100 spent on assets, it made $0.0838 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2292 %, implying that it generated $0.2292 on every 100 dollars invested. Encompass Health's management efficiency ratios could be used to measure how well Encompass Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.22, whereas Return On Tangible Assets are forecasted to decline to 0.05. At present, Encompass Health's Deferred Long Term Asset Charges is projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.46, whereas Total Assets are forecasted to decline to about 3.8 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 23.09 | 24.24 | |
| Tangible Book Value Per Share | 7.41 | 7.78 | |
| Enterprise Value Over EBITDA | 9.27 | 9.74 | |
| Price Book Value Ratio | 4.03 | 4.23 | |
| Enterprise Value Multiple | 9.27 | 9.74 | |
| Price Fair Value | 4.03 | 4.23 | |
| Enterprise Value | 9.2 B | 9.7 B |
Examining the leadership quality of Encompass Health Corp offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 2.4953 | Revenue 5.2 B | Quarterly Revenue Growth 0.119 | Revenue Per Share 52.255 | Return On Equity 0.2292 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Encompass Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Encompass Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Encompass Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Encompass Health Corporate Filings
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 13th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
13A | 8th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
10Q | 1st of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Encompass Health Earnings per Share Projection vs Actual
Encompass Health Corporate Directors
| Christopher Reidy | Independent Director | Profile | |
| John Chidsey | Independent Director | Profile | |
| Nancy Schlichting | Independent Director | Profile | |
| Yvonne Curl | Independent Director | Profile |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.26 | Dividend Share 0.62 | Earnings Share 4.25 | Revenue Per Share 52.255 | Quarterly Revenue Growth 0.119 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.